CD82 and Familial prostate cancer: Many studies have shown that decreased KAI1 expression could be a useful marker for metastatic, invasive, and prognostic factor in many human tumors, such as lung [6], breast [7, 8], gastric [9, 10], liver [11], colorectal [12], bladder[13], esophageal [14], and prostatic cancer [15].